Risk Prediction Model for Survival of Wait-List Patients on Axial CF-LVAD: A UNOS Database Analysis.

[1]  J. Morgan,et al.  Survival on the Heart Transplant Waiting List. , 2020, JAMA cardiology.

[2]  P. Jansz,et al.  Long-Term Survival of Patients With Advanced Heart Failure Receiving an Left Ventricular Assist Device Intended as a Bridge to Transplantation , 2020, Circulation. Heart failure.

[3]  D. Miller,et al.  Machine Intelligence in Cardiovascular Medicine. , 2020, Cardiology in review.

[4]  M. Keebler,et al.  Temporary left ventricular assist devices as a bridge to heart transplantation , 2020, Journal of cardiac surgery.

[5]  Kipp W. Johnson,et al.  Machine learning in cardiovascular medicine: are we there yet? , 2018, Heart.

[6]  Axel Haverich,et al.  Left Ventricular Assist Devices - A State of the Art Review. , 2018, Advances in experimental medicine and biology.

[7]  Robert L Kormos,et al.  Seventh INTERMACS annual report: 15,000 patients and counting. , 2015, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[8]  Mark S. Slaughter,et al.  Survival on the heart transplant waiting list: impact of continuous flow left ventricular assist device as bridge to transplant. , 2014, The Annals of thoracic surgery.

[9]  P. Eckman,et al.  Adult heart transplant: indications and outcomes. , 2014, Journal of thoracic disease.

[10]  Mark S. Slaughter,et al.  Outcomes of Left Ventricular Assist Device Implantation as Destination Therapy in the Post-REMATCH Era: Implications for Patient Selection , 2007, Circulation.